Language

Valet Consolidation at Tacoma General/Mary Bridge Children's Campuses

As of Monday, Nov. 12, 2018, valet parking services will no longer be offered at the main entrance of MultiCare Tacoma General Hospital on Martin Luther King Jr. Way. Patients may still be dropped off and picked up at that entrance and valet services are available at other hospital entrances. Learn More
Close

Women's Health Research

Women's Health Research Studies

Through the MultiCare Institute for Research & Innovation, women in our community have access to the latest treatment options through medical research. We rotate clinical trials for novelty medications and devices throughout the year for a wide variety of therapeutic areas including:

  • Contraception
  • Endometriosis
  • Female sexual dysfunction, libido
  • Hormone replacement therapy
  • Human papillomavirus (HPV)
  • Menopause
  • Overactive bladder
  • Uterine Fibroids
  • Vaginal infections

Principal Investigators:

Sub-Investigators:

Women's Health Studies Accepting Patients

HPV

HPV-301 Reveal I

Study Number: HPV-301—A prospective, randomized, double-blind, placebo-controlled Phase 3 study of VGX-3100 delivered intramuscularly followed by Electroporation Withcellectra 5PSP for the treatment of HPV-16 and/or HPV-18 related to high-grade squamous intraepithelial lesion (HSIL) of the cervix.

Study Info

Principal Investigator(s): James Rice, MD

Study CoordinatorLeann Harris, [email protected], 253-545-5839

Endometriosis

Spirit 2

Study Number: MVT-601-3102—An international Phase III randomized, double-blind, placebo-controlled efficacy and safety study to evaluate Relugolix administered with and without low-dose Estradiol and Norethindrone Acetate in women with endometriosis-associated pain.

Study Info

Principal Investigator(s): James Rice, MD

Study CoordinatorLeann Harris, [email protected], 253-545-5839

Female Sexual Dysfunction, Libido

VI-15-01

Study Number: VI-15-01—Viveve Geneveve Treatment of the Vaginal Introitus to Evaluate Safety and Efficacy

Study Info

Principal Investigator(s): James Rice, MD

Study Coordinator: Stacy Rebar, [email protected], 253-403-7251

Uterine Fibroids

Liberty 2

Study Number: MVT-601-3002—An international Phase III randomized, double-blind, placebo-controlled efficacy and safety study to evaluate Relugolix co-administered with and without low-dose Estradoil and Norethindrone Acetate in women with heavy menstrual bleeding associated with uterine fibroids.

Study Info

Principal Investigator(s): James Rice, MD

Study CoordinatorLeann Harris, [email protected], 253-545-5839


Asteroid 6

Study Number: Subgroup 2/BAY 1002670/16953 - An open-label, parallel group, randomized, multicenter study to assess the safety and efficacy of vilaprisan in subjects with uterine fibroids versus standard of care.

Study Info

Principal Investigator(s): James Rice, MD

Study CoordinatorLeann Harris, [email protected], 253-545-5839


ASTEROID 3

Study Number: BAYER 15787—A randomized, parallel-group, double-blind and open-label, placebo-controlled, multicenter study to assess the efficacy and safety of vilaprisan in subjects with uterine fibroids.

Study Info

Principal Investigator(s): James Rice, MD

Study Coordinator: Leann Harris, lmh[email protected], 253-545-5839

Overactive Bladder & Incontinence

Apollo

Study Number: 1839-201-021—A Phase III multicenter, randomized, double-blind, placebo-controlled, single-treatment, 2-stage, dose-finding study evaluating the efficacy and safety of BOTOX intravesical instillation in participants with overactive bladder and urinary incontinence.

Study Info

Principal Investigator(s): Krista Reagan, MD

Study CoordinatorDalia Sherif, [email protected], 253-403-2698

Bacterial Vaginosis

SMART GIVES

Study Number: SMART GIVES - Solubilized Metronidazole And/oR Terconazole Gels Intra-Vaginal Efficacy and Safety (SMART GIVES)

Study Info

Principal Investigator(s): James Rice, MD

Study Coordinator: Leann Harris, [email protected], 253-545-5839